 | Lwht Unexpected visits are turning California into a humpback whale hangout
NEW YORK ?When Donald Trump tried to buy the Buffalo Bills in 2014, investment bankers doubted the NFL would allow it but encouraged him to stay in the running, according to internal emails aired Tuesday at the former presidents civil fraud trial. Trump has little chance of being approved by the NFL, given that he had owned casinos and had a role in the rival USFLs 1980s antitrust suit against the NFL, then-Morgan Stanley executive K. Don Cornwell wrote to colleagues in April 2014. That being said, his strong show of support doesnt hurt the process. He pro [url=https://www.stanleycup.fr]gourde stanley[/url] bably does have the [url=https://www.stanleycup.fr]stanley france[/url] dough and claimed hed been courting the NFL, another Morgan Stanley banker, Jeffrey [url=https://www.stanleycups.co.nz]stanley cup[/url] Holzschuh, wrote back, adding: but never know the real facts with him. Three months later, Trump offered $1 billion cash for the Bills, becoming one of three known finalists seeking to buy the team after the death of founder and Hall of Fame owner Ralph Wilson. The owners of the NHLs Buffalo Sabres, Terry and Kim Pegula, ultimately bought the Bills for $1.4 billion. A group led by rock star Jon Bon Jovi had also been interested in acquiring the team.A decade later, Trumps failed Bills bid is one of the business moves under scrutiny in the trial of a lawsuit brought by New York Attorney General Letitia James. She accuses the ex-president and current Republican 2024 front-runner of deceiving banks, insurers and others by giving them financial statements that massively inflated the values of his assets.Trump denies any Tzew Ruling gives Sandusky back $4,900-a-month Penn State pension
NEW ORLEANS ?For the first time, a new drug given along with a cholesterol-lowering statin medicine has proved able to shrink plaque that is clogging arteries, potentially giving a way to undo some of the damage of heart disease.The difference was very small but doctors hope it will grow with longer treatment, and any reversal or stabilization of disease would be a win for patients and a long-sought goal.The drug, Amgen Inc.s Repatha, also drove LDL, or bad cholesterol, down to levels rarely if ever seen in people before. Heart patients are told to aim for below 70, but some study participants got as low as 15. There doesnt appear to be any level at which there is harm from too little LDL, and the lower patients went, the more their plaque shrank, said one study leader, the Cleveland Clinics Dr. Steven Nissen.Results were p [url=https://www.cups-stanley-cups.us]stanley us[/url] ublished Tue [url=https://www.cup-stanley-cup.ca]stanley mug[/url] sday by the Journal of the Ame [url=https://www.stanley-cups.it]stanley borraccia[/url] rican Medical Association and discussed at an American Heart Association conference.Statins such as Lipitor and Crestor curb cholesterol production. Repatha and a similar drug, Praluent, block PCSK9, a substance that interferes with the livers ability to remove cholesterol from the blood. Too much cholesterol, along with other substances, can build up and form plaque in arteries.The new drugs have drawbacks, though. Statins are pills sold as generics for as little as a dime a day. The new ones are biotech drugs that are expensive to make ?Repatha costs $14,000 a year and insurers often wont pay. They must be give |
